Delivery Order SPE2DB20D1047-SPE2DB25FF71P
- Not listed
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,402.52 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price, competitively awarded delivery order is set to be completed by November 13, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical distributor supporting federal medical procurement...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,752.22 on May 20, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this delivery order from its corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $14.5K delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- This delivery order, valued at $6,855.38, was awarded to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order falls under a child contract structure, leveraging the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price delivery order, valued at $4,050.57, is scheduled for completion by November 19, 2025, and will be performed at the vendor's location in Conshohocken, Pennsylvania. The contract was competitively awarded without any set-aside designation, reflecting AmerisourceBergen's established capability to meet federal...
- The Defense Logistics Agency has awarded a delivery order valued at $8,701.23 to AmerisourceBergen Drug Corp for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes with a ceiling value of $17,402.52. This firm fixed price delivery order, which carries an ultimate completion date of November 6, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $5,800.84 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on October 31, 2025, with an ultimate completion date of November 3, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,763.00 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/mL vials, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF71PDelivery Order
The Defense Logistics Agency awarded a $12.8K delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on July 14, 2025, with performance completion by July 15, 2025. This non-set-aside, firm fixed price contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger vehicle supporting the federal medical supply chain. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen's extensive federal portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.8k | 7/14/25 |